A. Geissler et al., CEREBRAL ABNORMALITIES IN PATIENTS WITH CIRRHOSIS DETECTED BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY AND MAGNETIC-RESONANCE-IMAGING, Hepatology, 25(1), 1997, pp. 48-54
Hepatic encephalopathy is a common problem in cirrhosis. The pathogene
sis of this complication of advanced liver disease still remains uncle
ar, Magnetic resonance spectroscopy was used to assess prospectively c
erebral metabolism in 51 patients with histologically proven cirrhosis
(Child-Pugh classes A, B, and C, 18, 18, and 15, respectively) and 36
healthy volunteers, According to the results of psychometric tests, o
vert hepatic encephalopathy, subclinical encephalopathy, and no enceph
alopathy were found in 14, 21, and 16 patients, respectively, Myoinosi
tol/creatine ratios in gray (.36 +/- .17) and white (.35 +/- .22) matt
er voxel were reduced significantly (P < .0001) in cirrhotic patients
compared with healthy volunteers (gray matter, .51 +/- .11; white matt
er, .64 +/- .16). in addition, patients showed a significant reduction
(P = .024) in white matter choline/creatine ratio (.77 +/- .27) compa
red with controls (.92 +/- .25), and glutamine/glutamate level was ele
vated in cirrhotic patients compared with controls (gray matter, P < .
0001; white matter, P = .036). Changes in cerebral myoinositol and glu
tamine/glutamate levels correlated significantly with the severity of
hepatic encephalopathy (P < .0001), However, these metabolic alteratio
ns were also detected in patients without hepatic encephalopathy (norm
al psychometric test results), N-acetyl aspartate/creatine ratios did
not differ between patients and controls, Magnetic resonance imaging d
etected bright basal ganglia in 37 patients, which correlated signific
antly with portal-systemic shunting and elevation of glutamine/glutama
te, but not with the degree of hepatic encephalopathy, Ln conclusion,
magnetic resonance imaging and spectroscopy showed that alterations of
cerebral metabolism are common in patients with cirrhosis, even witho
ut evidence of clinical or subclinical hepatic encephalopathy.